Date
Reset

California WC Claim Monitoring, Medical & Indemnity Development, AY 2005- 2014

New CWCI research that tracks average California workers’ comp medical loss, indemnity benefit and medical cost containment (MCC) payments on AY 2005 – 2014 lost-time claims finds mixed results, with more developed data on older claims showing paid medical losses and indemnity leveling out or declining, and less developed data on newer claims indicating that average amounts paid in the early stages of a claim are on the rise.

The Changing Nature and Cost of the Medical-Legal Process in California WC

A CWCI study reviews statutory, regulatory and judicial changes to the California workers’ comp medical-legal process over the past quarter century, provides updated data on the quantity, mix and cost of medical-legal services following the 2002-04 reforms, and generates benchmark data for future research on the impact of the 2012 reforms, which introduced IMR as the new means for resolving treatment disputes.

Utilization and Cost of Urine Drug Testing in California WC

A new CWCI Report to the Industry examines the issue of Urine Drug Testing in California workers’ comp, which now accounts for nearly half of all lab services and more than half of all payments for lab services in the California system.

Medical & Indemnity Benefit Trends, AY 2002 – 2014

Initial data on AY 2014 lost-time claims indicate that average medical payments at 3 and 6 months post injury declined following implementation of SB 863, though the 12- and 24-month data on claims from prior years still show average losses trending up, led by ongoing increases in payments for prescription drugs and DME.

California WC Independent Medical Review: 1st Quarter 2015 Outcomes

An analysis of 2015 independent medical review (IMR) decisions from the first quarter of 2015 shows no significant decline in IMR volume in the first three months of this year, even though the independent medical reviewers continue to concur with the utilization review (UR) physicians denial or modification of treatment in about 90 percent of the cases.